Azusa Sakurai, Ken Yamaguchi, Kentaro Ishida, Naoki Horikawa, Eri Kawai, Yasushi Kotani, Takaaki Yoshida, Naoya Kishimoto, Keiji Tatsumi, Minami Okudate, et al. Prognostic significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and monocyte-to-lymphocyte ratio in uterine carcinosarcoma. International journal of clinical oncology. 2025. 30. 3. 570-583
Haruka Suzuki, Kohei Hamada, Junzo Hamanishi, Akihiko Ueda, Ryusuke Murakami, Mana Taki, Rin Mizuno, Koichi Watanabe, Hanako Sato, Yuko Hosoe, et al. Artificial intelligence-based spatial analysis of tertiary lymphoid structures and clinical significance for endometrial cancer. Cancer Immunology, Immunotherapy. 2025. 74. 3
Haruka Suzuki, Kohei Hamada, Junzo Hamanishi, Akihiko Ueda, Ryusuke Murakami, Mana Taki, Rin Mizuno, Koichi Watanabe, Hanako Sato, Yuko Hosoe, et al. Artificial intelligence-based spatial analysis of tertiary lymphoid structures and clinical significance for endometrial cancer. Cancer immunology, immunotherapy : CII. 2025. 74. 3. 84-84
Yoshihide Inayama, Ken Yamaguchi, Kayoko Mizuno, Sachiko Tanaka-Mizuno, Ayami Koike, Nozomi Higashiyama, Mana Taki, Koji Yamanoi, Ryusuke Murakami, Junzo Hamanishi, et al. Changes in Physical Activity Across Cancer Diagnosis and Treatment Based on Smartphone Step Count Data Linked to a Japanese Claims Database: Retrospective Cohort Study. JMIR cancer. 2025. 11. e58093
Jumpei Ogura, Koji Yamanoi, Kentaro Ishida, Eijiro Nakamura, Shinji Ito, Naoki Aoyama, Yuki Nakanishi, Toshi Menju, Kosuke Kawaguchi, Yuko Hosoe, et al. A stearate-rich diet and oleate restriction directly inhibit tumor growth via the unfolded protein response. Experimental & molecular medicine. 2024
Ken Yamaguchi, Nozomi Higashiyama, Maki Umemiya, Yoshihide Inayama, Ayami Koike, Akihiko Ueda, Rin Mizuno, Mana Taki, Koji Yamanoi, Ryusuke Murakami, et al. Electronic patient-reported outcomes as digital therapeutics for patients with cancer: a narrative review of current practices and future directions. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY. 2025. 30. 1. 1-16
Ken Yamaguchi, Nozomi Higashiyama, Yoshihide Inayama, Ayami Koike, Akihiko Ueda, Mana Taki, Koji Yamanoi, Ryusuke Murakami, Junzo Hamanishi, Masaki Mandai. HIF2A shows potential tumor promoting effect and could be poor prognostic factor in ovarian clear cell carcinoma. GYNECOLOGIC ONCOLOGY. 2024. 190. S413-S413
Nozomi Higashiyama, Ken Yamaguchi, Maki Umemiya, Yoshihide Inayama, Ayami Koike, Akihiko Ueda, Rin Mizuno, Mana Taki, Koji Yamanoi, Ryusuke Murakami, et al. Voice-based depression assessment in patients with gynecological cancer. JOURNAL OF CLINICAL ONCOLOGY. 2024. 42. 23_SUPPL. 161-161
Nozomi Higashiyama, Ken Yamaguchi, Yoshihide Inayama, Ayami Koike, Akihiko Ueda, Sachiko Kitamura, Mana Taki, Koji Yamanoi, Ryusuke Murakami, Junzo Hamanishi, et al. A novel artificial intelligence algorism to evaluate the quality of life using heart rate variability. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2023. 33. SUPPL_4. A13-A13
Nozomi Higashiyama, Ken Yamaguchi, Yoshihide Inayama, Akihiko Ueda, Mana Taki, Sachiko Kitamura, Ryusuke Murakami, Koji Yamanoi, Junzo Hamanishi, Masaki Mandai. A machine learning-based prediction model for QOL using lifelogs which are related symptoms suffering the patients. CANCER SCIENCE. 2023. 114. 1265-1265
